Literature DB >> 18432506

Double heterozygosity for Hb New York [beta 113 GTG-->GAG; VAL-->GLU] and beta degrees-thalassemia mutations manifests as a thalassemia trait.

Anselm C W Lee1, Edmond S K Ma, Amy Y Y Chan, S C Szeto, L C Chan.   

Abstract

An extended family with three individuals affected by two different forms of double heterozygosity for beta-thalassemia and Hb New York is reported. Double heterozygosity of Hb New York [beta 113 GTG-->GAG; VAL-->GLU] and beta degrees codon 17 was detected in a fetus following prenatal screening for thalassemia. The father and a paternal aunt were also found to be heterozygous for Hb New York and beta degrees IVSII-654. Both adults had clinical and hematological features consistent with beta-thalassemia trait. The affected child was followed up after birth and manifested the typical course of a thalassemia trait, with no signs of organomegaly or overt hemolysis. Observations strongly suggest that double heterozygosity of Hb New York and beta degrees thalassemia has mild, if any, clinical symptoms, and is not an indication of therapeutic abortion when detected antenatally.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18432506     DOI: 10.1080/08880010801938199

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  1 in total

1.  Hb New York, preliminary results concerning the hematologic characteristics and the effects on thalassemia.

Authors:  Zhuru Cheng; Xiaonian Zhu; Dan Zeng; Qiao Feng; Baodong Tian; Haiqing Zheng; Shengkui Tan; Chunjiang Zhu
Journal:  Mol Biol Rep       Date:  2022-04-11       Impact factor: 2.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.